-
Zika virus could be used to treat brain cancer patients, study suggest
biospectrumasia
September 07, 2017
Glioblastoma is the most common form of brain cancer and is frequently lethal; most patients die within two years of diagnosis
-
FDA provides new tools for tests to detect Zika virus infection
biospectrumasia
August 21, 2017
Serological tests are especially important because there is often a small window when the virus' genetic material is detectable.
-
Novel assay detects Zika, differentiates from dengue and other flaviviruses
pharmafile
July 20, 2017
A collaboration between Swiss antibody therapeutics firm Humab BioMed and the University of California, Berkeley has given rise to an antibody-based assay which identify Zika infection, even differentiating it from other flaviviruses such as dengue.
-
Sun Pharma and NIV sign agreement to fight Zika, Chikungunya and dengue
expressbpd
June 28, 2017
Sun Pharma will provide drug molecules to NIV for testing against Zika, Chikungunya and dengue in model systems
-
Experimental Zika Vaccine Protects Mice Against Virus: Study
drugs.com
June 12, 2017
Just one dose of an experimental Zika vaccine provided mice with 100 percent protection against a potentially lethal dose of the virus, researchers report.
-
Following global tour, Zika virus knocks Indian doors
biospectrumasia
May 31, 2017
India reports its first three cases of Zika virus from Ahmedabad
-
Zika Virus assay for screening blood donations
europeanpharmaceuticalreview
May 26, 2017
Grifols now provides European countries accepting products with the CE marking with a test to detect the presence of the Zika virus in donated blood.
-
'Groundbreaking Strides' Made in Zika Vaccine Research
drugs.com
May 11, 2017
Development of a Zika vaccine is proceeding rapidly, but it still will be years before such a vaccine is available to the public, says the author of a new report on research efforts.
-
Epilepsy: Another Potential Zika Threat to Babies
drugs.com
April 18, 2017
Beyond its known links to birth defects and other problems, the Zika virus may also trigger cases of epilepsy in infants, warn experts from the U.S. Centers for Disease Control and Prevention.
-
Themis’ live attenuated recombinant Zika vaccine enters human testing
fiercepharma
April 12, 2017
Themis is the most recent group to usher a Zika vaccine to the clinic with its live attenuated recombinant candidate, following other efforts by Inovio, the NIH, and a partnership between the Walter Reed Army Institute of Research and Sanofi.